Literature DB >> 11906442

Prophylactic surgery to reduce breast cancer risk: a brief literature review.

B O Anderson1.   

Abstract

Prophylactic mastectomy reduces the likelihood of developing breast cancer among women at heightened risk for breast cancer, but at significant personal cost. Women at increased breast cancer risk on the basis of hormonal history, family history and/or genetic mutation carrier status may consider bilateral prophylactic mastectomy with or without reconstruction to reduce their cancer risk and/or decrease their chances of cancer mortality. Women having received mastectomy as treatment for breast cancer may request contralateral mastectomy to decrease the chances of developing a second breast primary. The potential oncologic value of these procedures must be weighed carefully on a case-by-case basis against the operation's physical and psychological morbidity. The purpose of this literature review is to provide a practice-oriented summary of recent clinical studies attempting to address the relative risks and benefits of preventive surgery for breast cancer. Data are included regarding the psychological factors surrounding patient selection and quality of life outcomes, which become the cornerstone of patient satisfaction and acceptance. Taken together, these data support the Society of Surgical Oncology position statement regarding the proper application of prophylactic surgery for breast cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11906442     DOI: 10.1046/j.1524-4741.2001.21059.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  4 in total

1.  Women's perceptions of the personal and family impact of genetic cancer risk assessment: focus group findings.

Authors:  Deborah J MacDonald; Linda Sarna; Jeffrey N Weitzel; Betty Ferrell
Journal:  J Genet Couns       Date:  2009-11-10       Impact factor: 2.537

2.  Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).

Authors:  Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Hanna Bandos; Joel L Weissfeld; Norman Wolmark
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-11

Review 3.  Risk-reducing mastectomy for the prevention of primary breast cancer.

Authors:  Nora E Carbine; Liz Lostumbo; Judi Wallace; Henry Ko
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

4.  Time to decide about risk-reducing mastectomy: a case series of BRCA1/2 gene mutation carriers.

Authors:  Mary McCullum; Joan L Bottorff; Mary Kelly; Stephanie A Kieffer; Lynda G Balneaves
Journal:  BMC Womens Health       Date:  2007-03-06       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.